Skip to main content
Home
  •  
  • Customers
  • Portal Login
  • Help

Search form

Main menu

  • About
    • History
    • Management
    • Careers
      • Current Opportunities
      • Life at BioClinica
      • Community Outreach
      • Compensation & Benefits
      • Employee Experience Video
    • Locations
      • Directions
      • Local Hotels
    • Contact Us
  • eClinical
    • OnPoint CTMS
    • Express EDC
      • Express EDCplus
    • Trident IWR / IVR
    • Supplies Optimizer
    • Services
      • Full Service EDC
      • Clinical Data Management
      • CDISC Implementation
      • Medical Coding
    • Support
      • Training
      • Submit an Issue
    • Partners
      • CRO Partners
      • Technology Partners
      • CRO Partner Program
    • Collateral
  • Imaging
    • Therapeutic Expertise
      • Oncology
      • Neurology
      • Musculoskeletal
      • Cardiovascular
      • Other Areas
    • Technology Solutions
      • WebSend
      • BioPACS
      • BioREAD
    • Imaging Modalities
    • Quality Process
      • Study Initiation and Startup
      • Image Collection and Quality Control
      • Independent Review
    • Collateral
  • Resources
    • Blog
    • White Papers & eBooks
    • Thought Leadership
    • Scientific Publications
      • Books and Book Sections
      • Authored Publications
      • BioClinica Studies
      • Abstracts and Proceedings
    • Clinical Trial Articles
    • Videos
  • News & Events
    • Press Releases
    • In The News
    • Events
    • Webinars
    • Media Contacts
  • Contact Us
    • General Inquiries
    • Request a Demo
Home / Blog

Information Brief at Alzheimer's Association Gala in Washington, DC

Colin Miller's picture
Submitted by Colin Miller on May 20, 2011 - 8:45am

Following on the theme of Alzheimer’s disease, there is a great summary paper from last month on the facts and figures (1) of this disease. Much of this was used as the information brief at the Alzheimer’s Association Gala in Washington, DC. Some of the facts are quite surprising, e.g. it is estimated that 5.4 million Americans have AD. Every 69 seconds someone in America develops Alzheimer’s disease. Total payments in 2011 for health care, long term care and hospital services for people age 65 years and older with AD and other dementias are estimated at $183 million.

Without wishing to get political, $183M is a huge sum of money for just one year of support for this chronic disease that is also now ranked as the 6th highest cause of death in the USA (2). Furthermore, as this second brief paper by Thies states, federal funding for cancer is about $6B annually, cardiovascular funding $4B, HIV $3B while Alzheimer’s disease is federally funded at $480M per year. Since the year 2000 to 2008, the incidence of Alzheimer’s disease has increased by 60% and the treatment and prevention of this debilitating condition is still a huge unmet medical need.

There are a number of therapies in development and BioClinica is involved in supporting the imaging component of many of these programs. With that said, the history of drug development in this field is littered with failures, in part because we still do not have a good handle on the etiology of conversion of those with mild cognitive impairment to Alzheimer’s disease. The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is starting to have data that will hopefully unlock many of the unknowns about this devastating disease. For those of us with a familial history of the disease and have seen it first hand, a cure cannot come too soon.

Have any questions about imaging therapies in development for Alzheimers’ disease? Please ask them in the comments below.

References:

  1. Alzheimer’s Association Report
    2011 Alzheimer’s Disease Facts & Figures
    by Alzheimer’s Association
    in Alzheimer’s & Dementia 7 (2011) 208-244
  2. Stopping a thief and killer: Alzheimer’s disease crisis demands greater commitment to research.
    Thies, W.
    Alzheimer’s & Dementia 7 (2011) 175-176
Category: 
Alzheimers disease
CTMS
  • Colin Miller's blog
  • Log in or register to post comments

Suggest A Topic

Got an idea for our Blog? We want to hear it!

Categories

  • Alzheimers disease
  • Arthritis
  • CDISC
  • Clinical Apps
  • Clinical IVR/IWR
  • Clinical Trial Standards
  • Clinical Trial Supply
  • Clinical Trials
  • CTMS
  • eClinical
  • Electronic Data Capture EDC
  • Medical Imaging
  • Oncology
  • Osteoarthritis
  • Osteoporosis
  • Rare Disease

Authors

Anonymous
Colin Miller
Jennifer Price
Stuart Jackson
Jeremiah Rehm
Bill Primwhere
Andy Dzik-Jurasz
Jonathan Andrus
Chahin Pachai
Nick Lenares
Ann Marie LaDue
Chris Englerth
Jeremy Daniel
Michael Schmidt
Robin Gray
Victoria Dunay

Recent blog posts

  • Clinical Trial Supply Optimization: Direct Learning from Client Users
  • BioClinica Oncology Symposium - May 14th 2013
  • The Forecast? Sunny Skies for Clinical Trial Resupplies!
  • Data Importing/Exporting and Integration Considerations
  • Get the Features You Want in eClinical and other Software Products
More
©  BioClinica. All Rights reserved.
  • Site Map
  • Terms of Use
  • Privacy Policy
  • Contact Us
Follow us on Follow us on FacebookFollow us on TwitterFollow us on LinkedInView our Blog